Robin Sherrington
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robin Sherrington
The proxy statement of Xenon Pharmaceuticals Inc. reports total compensation of $2,373,432 for Robin Sherrington in fiscal 2023, including a base salary of $410,552.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Xenon Pharmaceuticals Inc. (XENE)
Proxy statement
Start not stated–2024-04-26
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Xenon Pharmaceuticals Inc. (XENE) | Executive Vice President, Strategy and Innovation | $410,552 | $2,373,432 |
Recent activity
No call appearances or filed executive changes recorded yet.